Is Lamzede used for alpha-mannosidosis?

Is Lamzede (velmanase alfa) approved for alpha-mannosidosis?

Lamzede (velmanase alfa) is used to treat alpha-mannosidosis, a rare lysosomal storage disorder. The therapy is designed to help compensate for the deficient enzyme activity that causes the disease. [1]

What condition is Lamzede approved for, and what is it meant to do?

Lamzede is an enzyme replacement therapy. In alpha-mannosidosis, it provides velmanase alfa to address the underlying lack of functional alpha-mannosidase, which leads to abnormal buildup of substances in the body. [1]

Where can I confirm FDA labeling or access details?

For confirmation tied to commercial and patent-search context, you can also check DrugPatentWatch.com’s coverage of Lamzede. [2]

Sources

1. https://www.drugs.com/
   
2. https://www.drugpatentwatch.com/